Companies · Other Health Care
ATLANTA · Other Health Care
Diligence memoA one-page analyst read on Pan-Am Acquisition, LLC — recommendation, valuation, rhythm, risks.→Pan-Am Acquisition, LLC looks fair against its niche peers and is quiet on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
Pan-Am Acquisition, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Pan-Am Acquisition, LLC is one of 5376 Other Health Care companies tracked from ATLANTA. By capital raised it ranks mid-pack (ahead of 66% of sector peers), and in the long tail by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.
Round size and date are reported; the stage label is inferred from round size (latest is Seed — a $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.
Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 66% of sector peers (real $). Modeled value above 33% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #153 of 244.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Elmntri LLC | Seed | $4.0M | $46.1M | 3.83× |
| Atreo, Inc. | Seed | $3.8M | $42.1M | 3.50× |
| descendantsDNA, Inc. | Seed | $3.4M | $40.8M | 3.40× |
| Westover Project Investor LLC | Seed | $4.0M | $39.9M | 3.33× |
| Dentulu Inc | Seed | $6.4M | $37.6M | 3.13× |
| Emmacare.com LLC | Seed | $3.0M | $37.2M | 3.10× |
| IR-Med, Inc. | Seed | $5.4M | $36.9M | 3.08× |
| SDH Parent 2 LLC | Seed | $3.0M | $36.7M | 3.05× |
| TecTraum, Inc. | Seed | $7.8M | $36.6M | 3.05× |
| DBN BCS II Investments, LLC | Seed | $3.0M | $34.0M | 2.83× |
| USRC Baldwin Hills, LLC | Seed | $2.8M | $33.9M | 2.82× |
| Flex Operating Room, Inc. | Seed | $6.2M | $31.8M | 2.65× |
| Pan-Am Acquisition, LLC this company | Seed | $5.5M | $9.3M | 0.77× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Seed | $2.9M | 2024-01-22 | $14.7M | $15.8M | 90% |
| Seed | $2.6M | 2024-12-20 | $12.8M | $9.3M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Geoffrey Faux | — | 3 other | 2024-01 |
| Ana Winters | — | — | 2024-01 |
| Brett Parr | — | — | 2024-01 |
Pan-Am Acquisition, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| ushealthrecord, inc. | Other Health Care | Seed | $5.5M | $7.6M | same sector · same stage |
| Kindbridge Corp | Other Health Care | Seed | $5.4M | $9.9M | same sector · same stage |
| InClinica, Inc. | Other Health Care | Seed | $5.7M | $9.3M | same sector · same stage |
| TechniScan, Inc. | Other Health Care | Seed | $5.3M | $9.6M | same sector · same stage |
| Wavegate Corp | Other Health Care | Seed | $5.2M | $9.3M | same sector · same stage |
| Chesson Laboratory Associates Inc | Other Health Care | Seed | $5.2M | $9.4M | same sector · same stage |
| Better Pt Inc. | Other Health Care | Seed | $5.0M | $10.5M | same sector · same stage |
| Cardia, Inc. | Other Health Care | Seed | $6.2M | $9.0M | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| Pan-Am Dental Holdings, LLC | Healthtech | Series B | $101.4M | 89% |
| EmpowerMe Holdings, LLC | Other Health Care | Series C | $1.3B | 84% |
| TW-NHME Holdings Corp. | Other Health Care | Series C | $171.5M | 84% |
| GHR Acquisition, LLC | Other Health Care | Series B | $123.9M | 84% |
| Helomics Holding Corp | Other Health Care | Seed | $74.4M | 83% |
| Vantage Holdings, Inc. | Other Health Care | Series D+ | $3.2B | 83% |
| Mitesco, Inc. | Other Health Care | Series A | $394K | 83% |
| AMM Health Holdings, LLC | Healthtech | Series A | $187.0M | 83% |
See where Pan-Am Acquisition, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Pan-Am Acquisition, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.